Deloitte: M&A Life Sciences Trends

Life sciences M&A was a bright spot across the wider dealmaking world in 2023. Will this positive trend continue over the next 12 months? Deloitte thinks so, and is making five bold 2024 life sciences M&A predictions, which include another strong year for pharma M&A and a positive turn for the MedTech market. Find out what else Deloitte expects this year.

Read the full article: Deloitte: M&A Life Sciences Trends //

Source: https://www2.deloitte.com/us/en/pages/life-sciences-and-health-care/articles/mergers-and-acquisitions-trends-survey-life-sciences.html

Leave a Comment

Your email address will not be published.

Scroll to Top